Activation of pregnane X receptor inhibits experimental dermal fibrosis

Objective To assess the antifibrotic effects of pregnane X receptors (PXRs) in experimental dermal fibrosis. Methods The antifibrotic effects of PXR activation by 5-pregnen-3β-ol-20-one-16α-carbonitrile (PCN) were studied in the bleomycin model for prevention of dermal fibrosis and the modified bleomycin model for the treatment of established bleomycin-induced dermal fibrosis. Activation of canonical transforming growth factor (TGF)β signalling was analysed by immunofluorescence staining for phosphorylated smads. The antifibrotic effects of PXR activation were further studied in murine fibroblasts and murine T cells under Th2 conditions. In the T cell experiments, synthesis of the profibrotic cytokines, interleukin (IL)-4 and IL-13, was assessed by quantitative PCR, and IL-13 levels in the murine skin were determined by multiplex bead array technology. Results Activation of PXR effectively inhibited the development of bleomycin-induced dermal fibrosis and induced the regression of established dermal fibrosis as assessed by skin thickening, hydroxyproline content and myofibroblasts. Reduced levels of phosphorylated smad2 and smad3 suggested that the antifibrotic effects of PXRs were mediated by inhibition of canonical TGFβ signalling. While PXR activation appeared to have no direct effects on fibroblasts, it potently inhibited the release of the profibrotic cytokine, IL-13, from Th2 cells. Consistent with these findings, IL-13 levels were reduced in bleomycin-challenged murine skin upon PXR activation. Conclusions Our findings demonstrate a novel antifibrotic role for PXRs in inflammatory dermal fibrosis. The antifibrotic effects of PXRs appear to be indirect: PXR activation reduces the release of the Th2 cytokine, IL-13, from T cells resulting in decreased canonical TGFβ signalling.

[1]  T. Wynn,et al.  Mechanisms of fibrosis: therapeutic translation for fibrotic disease , 2012, Nature Medicine.

[2]  B. de Crombrugghe,et al.  β-catenin is a central mediator of pro-fibrotic Wnt signaling in systemic sclerosis , 2012, Annals of the Rheumatic Diseases.

[3]  G. Schett,et al.  Stimulation of soluble guanylate cyclase reduces experimental dermal fibrosis , 2012, Annals of the rheumatic diseases.

[4]  Oliver Distler,et al.  Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis , 2012, Nature Communications.

[5]  Lei Wang,et al.  Pregnane X receptor activation induces FGF19-dependent tumor aggressiveness in humans and mice. , 2011, The Journal of clinical investigation.

[6]  N. Alenina,et al.  Platelet-derived serotonin links vascular disease and tissue fibrosis , 2011, The Journal of experimental medicine.

[7]  G. Schett,et al.  Inactivation of the transcription factor STAT-4 prevents inflammation-driven fibrosis in animal models of systemic sclerosis. , 2011, Arthritis & Rheumatism.

[8]  G. Schett,et al.  Animal models of systemic sclerosis: prospects and limitations. , 2010, Arthritis & Rheumatism.

[9]  M. Schmuth,et al.  Modulation of T Lymphocyte Function by the Pregnane X Receptor , 2010, The Journal of Immunology.

[10]  P. Ascenzi,et al.  Nuclear receptors CAR and PXR: Molecular, functional, and biomedical aspects. , 2009, Molecular aspects of medicine.

[11]  K. Morimura,et al.  Pregnane X receptor activation ameliorates DSS-induced inflammatory bowel disease via inhibition of NF-κB target gene expression , 2007 .

[12]  David Abraham,et al.  Systemic sclerosis: a prototypic multisystem fibrotic disorder. , 2007, The Journal of clinical investigation.

[13]  C. J. Marek,et al.  Pregnane X receptor activators inhibit human hepatic stellate cell transdifferentiation in vitro. , 2006, Gastroenterology.

[14]  C. J. Marek,et al.  Pregnenolone-16alpha-carbonitrile inhibits rodent liver fibrogenesis via PXR (pregnane X receptor)-dependent and PXR-independent mechanisms. , 2005, The Biochemical journal.

[15]  M. Jinnin,et al.  Interleukin-13 Stimulates the Transcription of the Human α2(I) Collagen Gene in Human Dermal Fibroblasts* , 2004, Journal of Biological Chemistry.

[16]  L. Wakefield,et al.  IL-13 Activates a Mechanism of Tissue Fibrosis That Is Completely TGF-β Independent , 2004, The Journal of Immunology.

[17]  R. Homer,et al.  Interleukin-13 Induces Tissue Fibrosis by Selectively Stimulating and Activating Transforming Growth Factor β1 , 2001, The Journal of experimental medicine.

[18]  J. Lehmann,et al.  An Orphan Nuclear Receptor Activated by Pregnanes Defines a Novel Steroid Signaling Pathway , 1998, Cell.

[19]  M. Fujimoto,et al.  Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis. , 1997, The Journal of rheumatology.

[20]  K. Morimura,et al.  Pregnane X receptor activation ameliorates DSS-induced inflammatory bowel disease via inhibition of NF-kappaB target gene expression. , 2007, American journal of physiology. Gastrointestinal and liver physiology.